| Assessment of Ki67 in breast cancer: updated recommendations from the international Ki67 in breast cancer working group TO Nielsen, SCY Leung, DL Rimm, A Dodson, B Acs, S Badve, C Denkert, ... JNCI: Journal of the National Cancer Institute 113 (7), 808-819, 2021 | 443 | 2021 |
| Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses H Zhang, TU Ahearn, J Lecarpentier, D Barnes, J Beesley, G Qi, X Jiang, ... Nature genetics 52 (6), 572-581, 2020 | 301 | 2020 |
| An international study to increase concordance in Ki67 scoring MYC Polley, SCY Leung, D Gao, MG Mastropasqua, LA Zabaglo, ... Modern pathology 28 (6), 778-786, 2015 | 286 | 2015 |
| PIK3CA Mutations May Be Discordant between Primary and Corresponding Metastatic Disease in Breast Cancer J Dupont Jensen, AV Laenkholm, A Knoop, M Ewertz, R Bandaru, W Liu, ... Clinical Cancer Research 17 (4), 667-677, 2011 | 227 | 2011 |
| Evaluation of nine somatic variant callers for detection of somatic mutations in exome and targeted deep sequencing data AB Krøigård, M Thomassen, AV Lænkholm, TA Kruse, MJ Larsen PloS one 11 (3), e0151664, 2016 | 197 | 2016 |
| Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant T Frogne, RV Benjaminsen, K Sonne-Hansen, BS Sorensen, E Nexo, ... Breast cancer research and treatment 114, 263-275, 2009 | 186 | 2009 |
| The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical … PI Gonzalez‐Ericsson, ES Stovgaard, LF Sua, E Reisenbichler, Z Kos, ... The Journal of pathology 250 (5), 667-684, 2020 | 165 | 2020 |
| PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab JD Jensen, A Knoop, AV Lænkholm, M Grauslund, MB Jensen, ... Annals of oncology 23 (8), 2034-2042, 2012 | 165 | 2012 |
| Metastasis-related plasma membrane proteins of human breast cancer cells identified by comparative quantitative mass spectrometry R Leth-Larsen, R Lund, HV Hansen, AV Laenkholm, D Tarin, ON Jensen, ... Molecular & Cellular Proteomics 8 (6), 1436-1449, 2009 | 156 | 2009 |
| Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration SCY Leung, TO Nielsen, L Zabaglo, I Arun, SS Badve, AL Bane, J Bartlett, ... NPJ breast Cancer 2 (1), 1-9, 2016 | 143 | 2016 |
| PAM50 risk of recurrence score predicts 10-year distant recurrence in a comprehensive Danish cohort of postmenopausal women allocated to 5 years of endocrine therapy for … AV Lænkholm, MB Jensen, JO Eriksen, BB Rasmussen, AS Knoop, ... Journal of Clinical Oncology 36 (8), 735-740, 2018 | 141 | 2018 |
| Identification of genes for normalization of real-time RT-PCR data in breast carcinomas MB Lyng, AV Lænkholm, N Pallisgaard, HJ Ditzel BMC cancer 8, 1-11, 2008 | 135 | 2008 |
| Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer A Knoop, PA Andreasen, JA Andersen, S Hansen, AV Laenkholm, ... British Journal of Cancer 77 (6), 932-940, 1998 | 134 | 1998 |
| Classifications within molecular subtypes enables identification of BRCA1/BRCA2 mutation carriers by RNA tumor profiling MJ Larsen, TA Kruse, Q Tan, AV Laenkholm, M Bak, AE Lykkesfeldt, ... PloS one 8 (5), e64268, 2013 | 132 | 2013 |
| Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer Z Kos, E Roblin, RS Kim, S Michiels, BD Gallas, W Chen, KK van de Vijver, ... NPJ breast cancer 6 (1), 17, 2020 | 130 | 2020 |
| The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer KH Gravgaard, MB Lyng, AV Laenkholm, R Søkilde, BS Nielsen, T Litman, ... Breast cancer research and treatment 134, 207-217, 2012 | 121 | 2012 |
| Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy D Elias, H Vever, AV Laenkholm, MF Gjerstorff, CW Yde, AE Lykkesfeldt, ... Oncogene 34 (15), 1919-1927, 2015 | 114 | 2015 |
| Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors T Frogne, AV Laenkholm, MB Lyng, KL Henriksen, AE Lykkesfeldt Breast cancer research 11, 1-14, 2009 | 113 | 2009 |
| Phage Display–Derived Human Monoclonal Antibodies Isolated by Binding to the Surface of Live Primary Breast Cancer Cells Recognize GRP78 CG Jakobsen, N Rasmussen, AV Laenkholm, HJ Ditzel Cancer research 67 (19), 9507-9517, 2007 | 91 | 2007 |
| ER, HER2, and TOP2A expression in primary tumor, synchronous axillary nodes, and asynchronous metastases in breast cancer JD Jensen, A Knoop, M Ewertz, AV Laenkholm Breast cancer research and treatment 132, 511-521, 2012 | 88 | 2012 |
